Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Carolina Schinke

Concepts (320)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
78
2025
2998
8.840
Why?
Antibodies, Bispecific
9
2025
88
3.050
Why?
B-Cell Maturation Antigen
9
2025
99
2.550
Why?
Hematopoietic Stem Cell Transplantation
9
2024
577
2.160
Why?
Bone Marrow
11
2024
363
1.360
Why?
Leukemia, Plasma Cell
2
2020
32
1.330
Why?
Neoplasms, Plasma Cell
3
2024
36
1.290
Why?
Paraproteinemias
2
2022
72
1.280
Why?
Humans
93
2025
50516
1.240
Why?
Immunotherapy, Adoptive
6
2024
163
1.170
Why?
Monoclonal Gammopathy of Undetermined Significance
4
2024
112
1.150
Why?
Neoplasm, Residual
6
2022
160
1.130
Why?
Immunoglobulin Light Chains
2
2017
84
1.010
Why?
Transplantation, Autologous
10
2024
481
1.000
Why?
Immunoglobulins, Intravenous
1
2025
65
0.920
Why?
Gene Expression Regulation, Neoplastic
10
2024
833
0.920
Why?
Myelodysplastic Syndromes
5
2016
78
0.900
Why?
Immunoconjugates
2
2022
38
0.880
Why?
Mutation
8
2022
1281
0.870
Why?
Aged
26
2025
9743
0.830
Why?
Antibodies, Monoclonal
6
2023
462
0.800
Why?
Leukemia, Myeloid, Acute
4
2019
181
0.790
Why?
Prognosis
16
2024
1977
0.750
Why?
Health Personnel
1
2024
247
0.750
Why?
Gene Expression Profiling
10
2023
1025
0.730
Why?
Testis
1
2021
66
0.700
Why?
Signal Transduction
6
2024
1624
0.700
Why?
Middle Aged
25
2025
12613
0.680
Why?
Tumor Microenvironment
5
2024
222
0.680
Why?
Hematopoietic Stem Cells
3
2019
197
0.660
Why?
Male
33
2025
25913
0.660
Why?
Cell Proliferation
8
2023
985
0.640
Why?
Clonal Evolution
4
2024
56
0.630
Why?
Gene Expression
3
2018
610
0.620
Why?
Adult
21
2025
13584
0.570
Why?
Clinical Trials as Topic
6
2023
486
0.560
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2024
1000
0.560
Why?
Translocation, Genetic
5
2021
240
0.550
Why?
Thoracic Neoplasms
1
2016
13
0.520
Why?
Female
29
2025
27086
0.510
Why?
Aged, 80 and over
10
2025
3227
0.510
Why?
Plasmacytoma
1
2016
42
0.500
Why?
Receptors, Interleukin-8B
1
2015
4
0.490
Why?
Survival Analysis
8
2024
661
0.480
Why?
Interleukin-8
1
2015
85
0.470
Why?
Plasma Cells
5
2023
221
0.440
Why?
Receptors, G-Protein-Coupled
2
2024
49
0.440
Why?
Antineoplastic Agents
7
2024
1172
0.430
Why?
Combined Modality Therapy
4
2024
641
0.410
Why?
Stem Cell Transplantation
4
2024
179
0.410
Why?
Fluorodeoxyglucose F18
5
2021
189
0.400
Why?
Neutropenia
2
2023
116
0.390
Why?
DNA Methylation
4
2020
550
0.390
Why?
Oncogene Proteins, Fusion
2
2018
57
0.380
Why?
Neoplasms, Second Primary
2
2024
74
0.370
Why?
Chromosomes, Human, Pair 1
3
2023
92
0.370
Why?
Polycomb Repressive Complex 2
2
2021
46
0.370
Why?
Neoplasm Recurrence, Local
7
2024
629
0.360
Why?
Positron-Emission Tomography
4
2022
293
0.360
Why?
Epigenesis, Genetic
4
2020
372
0.360
Why?
Treatment Outcome
11
2025
5285
0.360
Why?
Evolution, Molecular
2
2021
95
0.350
Why?
Tretinoin
1
2010
50
0.340
Why?
Cell Line, Tumor
7
2024
1398
0.330
Why?
Risk Assessment
4
2024
1269
0.320
Why?
Transcription Factors
3
2023
565
0.310
Why?
Immunoglobulin kappa-Chains
2
2021
20
0.310
Why?
DNA-Binding Proteins
2
2021
418
0.290
Why?
Neoplasm Proteins
3
2020
320
0.290
Why?
Melanoma
1
2010
280
0.270
Why?
Transcriptome
2
2020
314
0.270
Why?
RANK Ligand
2
2024
187
0.260
Why?
Disease Progression
7
2023
829
0.260
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
2024
81
0.250
Why?
Biopsy
2
2018
588
0.250
Why?
Radiopharmaceuticals
3
2021
204
0.240
Why?
Skin Neoplasms
1
2010
491
0.240
Why?
Chemokine CCL3
1
2024
13
0.240
Why?
HMGB1 Protein
1
2024
21
0.240
Why?
Retrospective Studies
7
2025
6264
0.230
Why?
Dexamethasone
3
2024
432
0.230
Why?
T-Lymphocytes
5
2024
325
0.230
Why?
Kaplan-Meier Estimate
3
2021
464
0.230
Why?
Chemokine CXCL12
1
2024
33
0.230
Why?
Sialic Acid Binding Ig-like Lectin 2
1
2024
2
0.230
Why?
Antigens, CD19
1
2024
29
0.220
Why?
Mutation Rate
2
2021
35
0.220
Why?
Recurrence
6
2025
659
0.220
Why?
Bone Resorption
2
2024
302
0.220
Why?
Genome-Wide Association Study
1
2024
163
0.220
Why?
Myeloproliferative Disorders
1
2023
28
0.210
Why?
Cell Cycle
2
2021
226
0.210
Why?
Neoplasm Staging
2
2024
746
0.210
Why?
Proto-Oncogene Proteins B-raf
2
2020
80
0.200
Why?
Genomics
2
2023
279
0.200
Why?
Drug Resistance, Neoplasm
1
2024
316
0.200
Why?
Qualitative Research
1
2024
348
0.190
Why?
Osteolysis
1
2022
74
0.190
Why?
Drug Approval
1
2022
47
0.190
Why?
Waldenstrom Macroglobulinemia
1
2022
40
0.190
Why?
Lymphoma, B-Cell
1
2022
49
0.190
Why?
Polymorphism, Single Nucleotide
1
2024
474
0.190
Why?
Osteocytes
1
2024
224
0.190
Why?
Hematologic Diseases
1
2021
21
0.190
Why?
Epigenomics
1
2021
68
0.190
Why?
Bone Marrow Transplantation
1
2022
136
0.190
Why?
Patient Participation
1
2022
70
0.190
Why?
Genetic Predisposition to Disease
1
2024
510
0.190
Why?
Mice
6
2024
5687
0.180
Why?
Chromosome Deletion
2
2023
134
0.180
Why?
Abnormal Karyotype
1
2021
5
0.180
Why?
Risk Factors
8
2024
3723
0.180
Why?
Drug Design
2
2013
119
0.180
Why?
Myeloma Proteins
1
2021
26
0.180
Why?
Immunoglobulin A
1
2021
44
0.180
Why?
Communicable Diseases
1
2021
52
0.180
Why?
Diffusion Magnetic Resonance Imaging
2
2019
125
0.180
Why?
Antibodies, Monoclonal, Humanized
1
2022
226
0.180
Why?
Genes, Tumor Suppressor
2
2021
73
0.180
Why?
Hematologic Neoplasms
1
2022
99
0.170
Why?
Gene Expression Regulation, Leukemic
1
2020
29
0.170
Why?
Salvage Therapy
1
2021
137
0.170
Why?
Practice Guidelines as Topic
1
2023
468
0.170
Why?
Immunoglobulin G
1
2021
190
0.170
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.170
Why?
Neoplasm Invasiveness
1
2021
269
0.170
Why?
Bone Diseases
1
2021
96
0.170
Why?
Gene Amplification
1
2019
56
0.170
Why?
Gene Regulatory Networks
1
2020
106
0.160
Why?
Atrial Fibrillation
1
2022
188
0.160
Why?
Chromosomal Instability
1
2019
16
0.160
Why?
Hematopoiesis, Extramedullary
1
2019
9
0.160
Why?
United States
3
2024
4955
0.160
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.160
Why?
Healthcare Disparities
1
2022
281
0.160
Why?
Comorbidity
1
2021
623
0.150
Why?
Sulfonamides
1
2019
126
0.150
Why?
Models, Statistical
1
2020
226
0.150
Why?
Animals
8
2024
13124
0.150
Why?
Spleen
1
2019
169
0.150
Why?
Spinal Fractures
1
2018
38
0.150
Why?
Phosphotransferases
1
2018
16
0.150
Why?
Bacteremia
1
2019
89
0.150
Why?
Adipocytes
1
2018
126
0.140
Why?
Cell Differentiation
3
2022
640
0.140
Why?
Gene Rearrangement
1
2018
65
0.140
Why?
Disease-Free Survival
4
2019
444
0.140
Why?
Kidney Function Tests
1
2017
51
0.140
Why?
Hexokinase
1
2017
17
0.140
Why?
Chromosomes, Human, Pair 17
1
2017
34
0.140
Why?
Calcification, Physiologic
1
2017
40
0.140
Why?
Glomerular Filtration Rate
1
2017
119
0.140
Why?
Chromosome Aberrations
2
2023
280
0.140
Why?
HIV Infections
1
2021
352
0.140
Why?
Survival Rate
4
2020
909
0.140
Why?
Pelvis
1
2017
66
0.140
Why?
Histoplasma
1
2016
23
0.130
Why?
CA-125 Antigen
1
2016
16
0.130
Why?
Receptor, TIE-2
1
2016
16
0.130
Why?
Cardiomyopathy, Restrictive
1
2016
5
0.130
Why?
Histoplasmosis
1
2016
44
0.130
Why?
Urea
1
2016
81
0.130
Why?
Indazoles
1
2016
46
0.130
Why?
p38 Mitogen-Activated Protein Kinases
1
2016
93
0.130
Why?
Gene Expression Regulation, Enzymologic
1
2017
179
0.130
Why?
Remission Induction
3
2024
208
0.130
Why?
Gastrointestinal Diseases
1
2016
125
0.120
Why?
Tumor Suppressor Protein p53
1
2017
213
0.120
Why?
Proteasome Inhibitors
1
2016
104
0.120
Why?
Immunologic Factors
1
2016
111
0.120
Why?
Cell Cycle Checkpoints
1
2015
29
0.120
Why?
Kidney Diseases
1
2017
213
0.120
Why?
Time Factors
2
2021
2935
0.120
Why?
Cluster Analysis
1
2015
219
0.120
Why?
Xenograft Model Antitumor Assays
1
2015
212
0.120
Why?
Myocardium
1
2017
445
0.110
Why?
Thrombopoiesis
1
2014
5
0.110
Why?
Hydrazines
1
2014
16
0.110
Why?
Benzoates
1
2014
21
0.110
Why?
Neoplastic Stem Cells
1
2015
98
0.110
Why?
Immunotherapy
1
2016
235
0.110
Why?
Demography
2
2024
94
0.110
Why?
Cystatin M
2
2024
19
0.110
Why?
Disease Models, Animal
2
2016
1436
0.110
Why?
Cell Survival
1
2015
589
0.110
Why?
Cross-Sectional Studies
3
2023
1608
0.100
Why?
Pyrazoles
1
2014
111
0.100
Why?
Chromosomes, Human, Pair 7
1
2012
29
0.100
Why?
Clone Cells
2
2023
70
0.100
Why?
Cardiovascular Diseases
1
2017
460
0.100
Why?
STAT3 Transcription Factor
1
2012
77
0.100
Why?
Chromatin
2
2024
137
0.100
Why?
Cell Transformation, Neoplastic
1
2013
181
0.100
Why?
Thalidomide
1
2014
378
0.100
Why?
Follow-Up Studies
3
2024
2242
0.090
Why?
Flow Cytometry
2
2012
474
0.090
Why?
In Situ Hybridization, Fluorescence
2
2023
231
0.090
Why?
Leukemia, Promyelocytic, Acute
1
2010
11
0.090
Why?
Luciferases
1
2010
49
0.090
Why?
Response Elements
1
2010
29
0.090
Why?
Gene Silencing
1
2010
115
0.090
Why?
Alleles
2
2021
255
0.080
Why?
Tumor Burden
2
2020
130
0.080
Why?
Recombinant Fusion Proteins
1
2010
179
0.080
Why?
Transfection
1
2010
356
0.080
Why?
Molecular Structure
1
2010
296
0.080
Why?
Histones
2
2021
297
0.080
Why?
Apoptosis
2
2014
1097
0.080
Why?
DNA Copy Number Variations
2
2021
109
0.080
Why?
Syndecan-1
2
2021
75
0.070
Why?
Case-Control Studies
2
2024
1155
0.070
Why?
Tumor Cells, Cultured
2
2020
457
0.060
Why?
Imaging, Three-Dimensional
2
2017
151
0.060
Why?
Gene Expression Regulation
1
2010
955
0.060
Why?
Transmembrane Activator and CAML Interactor Protein
1
2024
6
0.060
Why?
Mendelian Randomization Analysis
1
2024
7
0.060
Why?
Arkansas
2
2021
1984
0.060
Why?
Telomere
1
2024
35
0.060
Why?
Mitogen-Activated Protein Kinase Kinases
1
2024
31
0.060
Why?
Killer Cells, Natural
1
2024
106
0.060
Why?
Ferritins
1
2024
30
0.060
Why?
Myeloid Progenitor Cells
1
2023
17
0.050
Why?
X-Ray Microtomography
1
2024
79
0.050
Why?
CD8-Positive T-Lymphocytes
1
2024
125
0.050
Why?
Antibodies
1
2024
153
0.050
Why?
B-Lymphocytes
1
2024
171
0.050
Why?
Receptors, Antigen, T-Cell
1
2023
48
0.050
Why?
Cell Communication
1
2023
68
0.050
Why?
Neoplasms
1
2013
1255
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Patients
1
2022
48
0.050
Why?
Geography
1
2022
60
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
32
0.050
Why?
Patient Selection
1
2023
259
0.050
Why?
United States Food and Drug Administration
1
2022
90
0.050
Why?
Infant
1
2010
3629
0.050
Why?
Oncogenes
1
2021
57
0.050
Why?
Phylogeny
1
2022
236
0.050
Why?
Tomography, X-Ray Computed
2
2017
1169
0.050
Why?
SOXC Transcription Factors
1
2021
13
0.050
Why?
Transcriptional Activation
1
2021
119
0.050
Why?
Lymphoma, Large B-Cell, Diffuse
1
2022
90
0.050
Why?
Pyrimidines
1
2022
191
0.040
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
67
0.040
Why?
Cyclin D2
1
2020
20
0.040
Why?
Aneuploidy
1
2020
18
0.040
Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
30
0.040
Why?
Chromosomes, Human, Pair 11
1
2020
49
0.040
Why?
Histone Code
1
2020
30
0.040
Why?
Cyclin D1
1
2020
52
0.040
Why?
ras Proteins
1
2020
64
0.040
Why?
Genome, Human
1
2021
109
0.040
Why?
Protein Kinase Inhibitors
1
2022
204
0.040
Why?
Chromosomes, Human, Pair 14
1
2020
66
0.040
Why?
DNA, Neoplasm
1
2020
143
0.040
Why?
Health Status Disparities
1
2022
202
0.040
Why?
Genetic Variation
1
2020
207
0.040
Why?
DNA Mutational Analysis
1
2020
175
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2020
170
0.040
Why?
Osteoclasts
1
2022
427
0.040
Why?
Multivariate Analysis
1
2021
583
0.040
Why?
Gram-Positive Bacterial Infections
1
2019
27
0.040
Why?
Computational Biology
1
2020
215
0.040
Why?
Pseudomonas Infections
1
2019
48
0.040
Why?
Syndrome
1
2019
240
0.040
Why?
Fractures, Compression
1
2018
17
0.040
Why?
Randomized Controlled Trials as Topic
1
2021
573
0.040
Why?
Promoter Regions, Genetic
1
2020
465
0.040
Why?
Receptor Protein-Tyrosine Kinases
1
2018
46
0.040
Why?
Protein-Tyrosine Kinases
1
2018
88
0.040
Why?
False Positive Reactions
1
2017
59
0.030
Why?
Bone and Bones
1
2021
478
0.030
Why?
Amino Acid Sequence
1
2018
574
0.030
Why?
Databases, Factual
1
2020
674
0.030
Why?
Itraconazole
1
2016
35
0.030
Why?
Alkaline Phosphatase
1
2017
93
0.030
Why?
beta-Glucans
1
2016
23
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Angiopoietin-1
1
2016
16
0.030
Why?
Amphotericin B
1
2016
102
0.030
Why?
Genes, p53
1
2016
49
0.030
Why?
NF-kappa B
1
2018
315
0.030
Why?
Ileum
1
2016
85
0.030
Why?
Intestinal Obstruction
1
2016
36
0.030
Why?
Glycolysis
1
2016
69
0.030
Why?
Gene Knockdown Techniques
1
2016
105
0.030
Why?
Colonoscopy
1
2016
100
0.030
Why?
Models, Genetic
1
2016
172
0.030
Why?
Genomic Instability
1
2016
90
0.030
Why?
Fever
1
2016
112
0.030
Why?
Drug Screening Assays, Antitumor
1
2016
131
0.030
Why?
Staphylococcal Infections
1
2019
267
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
106
0.030
Why?
Logistic Models
1
2018
899
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2016
140
0.030
Why?
Heart
1
2017
339
0.030
Why?
Proportional Hazards Models
1
2016
415
0.030
Why?
Algorithms
1
2018
628
0.030
Why?
Echocardiography
1
2017
400
0.030
Why?
Weight Loss
1
2016
245
0.030
Why?
Megakaryocyte Progenitor Cells
1
2014
1
0.030
Why?
Young Adult
1
2024
4107
0.030
Why?
Antifungal Agents
1
2016
331
0.030
Why?
Longitudinal Studies
1
2016
735
0.030
Why?
Models, Immunological
1
2013
7
0.030
Why?
Chemistry, Pharmaceutical
1
2013
33
0.030
Why?
Early Diagnosis
1
2013
88
0.030
Why?
Karyotyping
1
2012
65
0.030
Why?
Azacitidine
1
2012
34
0.030
Why?
Primary Cell Culture
1
2012
60
0.020
Why?
Cell Lineage
1
2012
83
0.020
Why?
Polymerase Chain Reaction
1
2013
449
0.020
Why?
Child
1
2024
6910
0.020
Why?
Enzyme Inhibitors
1
2013
377
0.020
Why?
Antigens, CD
1
2012
222
0.020
Why?
Magnetic Resonance Imaging
1
2017
1556
0.020
Why?
Cytokines
1
2013
606
0.020
Why?
Reproducibility of Results
1
2013
1199
0.020
Why?
Cohort Studies
1
2013
1452
0.020
Why?
Schinke's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description